Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Brennan James Decker
Observed names:
Brennan Decker,
Brennan J. Decker
Institution:
Foundation Medicine (United States)
Observed institution:
Foundation Medicine (United States)
OpenAlex ID:
A5105217687
Landscape of homologous recombination reversion mutations in gynecologic malignancies.
2022
·
Susan M. Domchek
, Kim Anna Reiss
, et al.
·
Journal of Clinical Oncology
·
4
Landscape of homologous recombination reversion mutations in pancreaticobiliary malignancies.
2022
·
Brennan James Decker
, Susan M. Domchek
, et al.
·
Journal of Clinical Oncology
·
3
Phenotypic POLE Variant Classification Identifies Patients Who May Have Favorable Prognosis and Benefit from Immunotherapy
2026
·
Rachel B. Keller-Evans
, Zoe Fleischmann
, et al.
·
Journal of Molecular Diagnostics
·
2
BRCA1/2 reversion mutations (BRCArev) in advanced prostate cancer in the absence of prior PARP inhibitor (PARPi) therapy.
2024
·
Douglas I. Lin
, Elizabeth L
, et al.
·
Journal of Clinical Oncology
·
1
PDF
Liquid biopsy (LB)-based comprehensive genomic profiling (CGP) of circulating tumor DNA (ctDNA) for the evaluation of patients with myeloid neoplasms.
2022
·
Douglas A Mata
, Mina L. Xu
, et al.
·
Journal of Clinical Oncology
·
1
Utility of liquid biopsy (LB)-based comprehensive genomic profiling (CGP) of circulating tumor DNA (ctDNA) in lymphomas and plasma cell neoplasms.
2022
·
Douglas A Mata
, Vignesh Shanmugam
, et al.
·
Journal of Clinical Oncology
·
1
BRCA1/2 and PALB2 short variants (SVs) contributed by clonal hematopoiesis (CH) in liquid biopsies (LBx) from patients with advanced pancreatic cancer (PC).
2025
·
Kim Anna Reiss
, Katherine L. Nathanson
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
7
Citation count:
12
H-index:
2
I10-index:
Year
Topic
Type